<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=461926130648047&ev=PageView&noscript=1">

Get ready – flu and influenza-like illness season is here

As the season of influenza and influenza-like illnesses (ILI) is here, it’s time to get your lab ready with the QIAstat-Dx Respiratory Panel. It’s the only multiplex respiratory panel that provides Ct values for 21 bacterial and viral targets, as well as an error-proof workflow for greater ease of use and reduced risk of contamination. Get in touch with us today to learn how QIAstat-Dx can improve your lab’s services to patients and clinicians.

Get the details on the 2019–2020 respiratory season

A recent report from the Australian Department of Health has indicated high flu activity early in their flu season (1).

Download the infographic to see which strains are expected to dominate this year, as well as new data on the Australian flu season.

Discover the benefits of QIAstat-Dx for respiratory testing

Watch this video clip with Dr. Benoit Visseaux and Dr. Celestin Alexis Agbessi discussing how syndromic testing makes a difference in testing for respiratory illnesses in an emergency room setting.

Stay up to date with the most recent news

Check out the latest updates on flu surveillance in your region.

Our specialists are ready to answer your questions about QIAstat-Dx. Please provide us with your contact information and we will get in touch with you soon.

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further contests, special offers and product information.*

Thank you for your interest in the QIAstat-Dx Analyzer.

We have received your request and will get back to you soon.

In the meantime, please feel free to visit QIAstat-Dx.com to find out more about QIAstat-Dx, learn about its panels, watch webinars and more.

Best regards,
Your QIAstat-Dx team

The QIAstat-Dx Analyzer and the QIAstat-Dx Respiratory Panel are intended for in vitro diagnostic use.


1. Australian Government Department of Health. (2019) Australian Influenza Surveillance Report. Number 5, June 17–30.

* Disclaimer:
QIAGEN will use your personal information to enrich customer profiles in our database.  Subject to your consent given above, QIAGEN may furthermore use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation. For further details please refer to our Privacy Policy. If you reside in the EU and do not tick the box to stay in touch, we will not contact you for marketing purposes unless you have previously opted in to receive updates from QIAGEN.